Life Sciences: Regulatory/Compliance | Global

Highly rated for its international work across a broad range of regulated industries, Arnold & Porter frequently acts as global counsel to a host of leading multinational companies in the life sciences sector. The firm is particularly highlighted for its high-end expertise in regulatory issues and product liability cases, coordinating advice on the global development and distribution of pharmaceuticals and medical devices across the USA, the EU and Asia.

The firm's offices across the USA play a significant role in international work. Washington, DC hosts the largest proportion of the firm's resources and acts as a key hub for the firm's global practice, particularly in relation to investigations, international trade and compliance. The firm's US-based teams are renowned for their work advising large pharma companies on the development and commercialisation of products worldwide, with cross-border issues involving the USA and China being a particular theme of the firm's recent activity.

Hogan Lovells is an internationally oriented firm which combines a well-established presence in the USA and an impressive network of offices in other key jurisdictions throughout Europe, Asia, Australia, the Middle East and Africa. The firm's US presence remains an important contributor to its worldwide success and provides a strong transatlantic platform through frequent collaboration with the firm's London office. Washington, DC serves as a key location for the firm's international trade and arbitration practice, while the firm's US-based lawyers also play a significant role in coordinating cross-border advice on regulated industries and M&A transactions.

Sidley Austin is frequently sought out by international clients for its global-sector expertise, with the firm's focus built around strong relationships with clients in financial service, energy, life sciences and biotechnology. While the firm's US base remains the key central hub of its global operations, Sidley Austin also attracts ample praise for its ability to join up experts across its platform throughout Europe and Asia, with offices in London, Singapore and China among others also playing a vital role in the firm's international appeal. The firm has an impressive ability to handle global transactions, disputes and investigations, enabling it to provide a comprehensive service on sophisticated matters for clients in its key industry groups.

King & Spalding has a well-regarded practice capable of acting for clients on a wide array of regulatory matters. The firm is noted for its expertise in FDA approvals, Congressional investigations and pricing issues. Its clients include pharmaceutical and medical device companies of all sizes.

Morgan, Lewis & Bockius offers its clients expertise across a broad range of practice areas from strategically-situated offices in the USA, Europe, Asia and the Middle East. It is sought out to advise on cross-border M&A and financing, international arbitration and regulatory investigations work by a clientele that includes multinational corporations and private equity funds. The US offices are particularly well placed to advise on matters concerning Latin American jurisdictions, and its regulatory expertise makes it a popular choice for clients in the energy, life sciences and technology sectors.

Ropes & Gray provides an integrated international offering with a strong global focus on financial services, life sciences and pharmaceuticals. The firm's US offices act as its primary driving force for international work, with Boston and New York frequently leading cross-border work, typically coordinating global transactions for major private equity funds and corporations. Key areas of geographic strength include Asian markets, and Ropes & Gray is often considered a popular choice by US and Asian clients for investments from the USA into China and Japan, where the firm can also offer locally based US law-qualified experts. The US team also works in a seamless manner with the firm's London office, particularly for the funds and corporate side of the practice.